K. Okada

发表

Different effects of 4-(4'-chlorobenzyloxy)benzoic acid (MII) on lipid synthesis and cell growth in human and mouse skin fibroblasts.

T. Okazaki, K. Yagasaki, T. Irikura, 1985, Journal of pharmacobio-dynamics.

Effect of KCD-232, a new hypolipidemic agent, on serum lipoprotein changes in hepatoma-bearing rats

K. Yagasaki, T. Irikura, K. Takagi, 1985, Lipids.

Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on triglyceride and fatty acid metabolism in rats.

T. Mochizuki, K. Yagasaki, T. Irikura, 1984, Biochemical pharmacology.

Cephem antibiotics and alcohol metabolism.

H. Fujimura, M. Nozaki, K. Tsurumi, 1985, The Japanese journal of antibiotics.

Effect of glucose on lipolysis and on release of lipolytic products in isolated adipocytes.

C. Naito, K. Okada, 1975, The American journal of physiology.

Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats.

T. Mochizuki, K. Yagasaki, T. Irikura, 1985, Biochemical pharmacology.

Reduction of Fructose-induced Hypertriglyceridemia and Fatty Liver in Rats by 4-(4′-Chlorobenzyloxy)benzyl Nicotinate (KCD-232)

K. Yagasaki, T. Irikura, K. Takagi, 1984 .

Effect of KCD-232, a New Hypolipidemic Compound, on Hyperlipidemia in Experimental Nephrotic Syndrome Rats

T. Mochizuki, T. Irikura, K. Takagi, 1984 .

Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 3rd communication: inhibitory effects on leucocyte emigration and proliferation of granulation.

H. Fujimura, K. Tsurumi, J. Hasegawa, 1986, Arzneimittel-Forschung.